Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Auditor change
Consulting agrmnt
|
|
PIERIS PHARMACEUTICALS, INC. (PIRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/24/2022 |
8-K
| Investor presentation |
| 09/21/2020 |
8-K
| Quarterly results |
| 11/12/2019 |
8-K
| Quarterly results |
| 10/02/2019 |
8-K
| Quarterly results |
| 10/01/2019 |
8-K
| Investor presentation|
Docs:
|
"Bruns IB,1 Fitzgerald MF,1 Mensing G,1 Tsung M,1 Pardali K,2 Gardiner P,3 Keeling DJ,2 Axelsson LT,2 Olsson M,4 Ghobadi C,2 Walsh O,5 McLendon K,6 Farinola N,7 Hatchuel L,8 Close DR2 1 Pieris Pharmaceuticals, Boston, MA," |
|
| 05/19/2015 |
8-K
| Investor presentation |
| 03/09/2015 |
8-K
| Investor presentation |
|
|